Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | $1.34 | $1.34 | $1.34 |
Q2 2024 | 1 | $1.54 | $1.54 | $1.54 |
Q3 2024 | 1 | -$0.36 | -$0.36 | -$0.36 |
Q1 2025 | 0 | $0.00 | $0.00 | $0.00 |
ZIVO Bioscience, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.67 earnings per share for the quarter, missing analysts' consensus estimates of $-0.39 by $0.28. The company had revenue of 31,500 for the quarter and had revenue of 27,650 for the year. ZIVO Bioscience, Inc. has generated $-5 earnings per share over the last year ($-4.6 diluted earnings per share) and currently has a price-to-earnings ratio of -5.5. ZIVO Bioscience, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/14/2024 | Q3 2024 | -$0.39 | -$0.67 | -0.28 | $31,500 | $31,500 |
08/14/2024 | Q2 2024 | -$0.42 | -$2.78 | -2.36 | $0 | $0 |
05/13/2024 | Q1 2024 | -$0.80 | -$0.47 | 0.33 | $35,720 | |
03/15/2024 | Q4 2023 | -$1.10 | $11,800 | |||
11/13/2023 | Q3 2023 | -$1.05 | $106,000 | $11,800 | ||
08/14/2023 | Q2 2023 | -$1.32 | $4,050 | |||
05/10/2023 | Q1 2023 | -$0.24 | -$1.26 | -1.02 | $0 | |
03/14/2023 | Q4 2022 | -$1.69 | $0 | |||
11/14/2022 | Q3 2022 | -$0.23 | -$1.28 | -1.05 | $0 | |
08/04/2022 | Q2 2022 | -$0.21 | -$1.32 | -1.11 | $0 | |
05/13/2022 | Q1 2022 | -$1.20 | -$1.29 | -0.09 | $0 | |
04/22/2022 | Q4 2021 | -$1.47 | $0 | |||
11/15/2021 | Q3 2021 | -$1.79 | $0 | |||
08/16/2021 | Q2 2021 | -$1.71 | $0 | |||
05/17/2021 | Q1 2021 | -$2.56 | $0 | |||
02/25/2021 | Q4 2020 | -$2.21 | $19.98 M | |||
11/12/2020 | Q3 2020 | -$4.13 | $0 | |||
08/13/2020 | Q2 2020 | -$1.39 | $0 | |||
05/11/2020 | Q1 2020 | -$3.04 | $20,000 | |||
03/26/2020 | Q4 2019 | -$5.48 | $0 |
ZIVO Bioscience, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based off last year's report dates.
The conference call for ZIVO Bioscience, Inc.'s latest earnings report can be listened to online.
The conference call transcript for ZIVO Bioscience, Inc.'s latest earnings report can be read online.
ZIVO Bioscience, Inc. (:ZIVO) has a recorded annual revenue of $27,650.
ZIVO Bioscience, Inc. (:ZIVO) has a recorded net income of $27,650. ZIVO Bioscience, Inc. has generated $-4.6 earnings per share over the last four quarters.
ZIVO Bioscience, Inc. (:ZIVO) has a price-to-earnings ratio of -5.5 and price/earnings-to-growth ratio is -0.78.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED